We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · October 27, 2019

Low Fasting C-Peptide Concentration Associated With Hypoglycemia in Type 2 Diabetes

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Fasting C-Peptide, a Biomarker for Hypoglycaemia Risk in Insulin-Naïve People With Type 2 Diabetes Initiating Basal Insulin Glargine 100 U/mL
Diabetes Obes Metab 2019 Oct 13;[EPub Ahead of Print], W Landgraf, DR Owens, BM Frier, M Zhang, GB Bolli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading